Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

We evaluated the safety and efficacy of allogeneic, ex-vivo expanded, NK cells, MG4101, in patients with refractory or relapsed AML. The relationship between immunological characteristics and clinical responses was analyzed. Between April 2018 and February 2020, 11 patients (male:female = 5:6) were treated with MG4101. Of eight evaluable patients, two (25.0%) showed partial response and two (25.0%) showed stable disease. The median overall survival was 3.4 months (95% confidence interval [95% CI], 2.5-4.3 months), and the allogeneic hematopoietic stem cell transplantation (HSCT) censored duration of response was 2.9 months (95% CI, 1.5-4.4 months). Two patients underwent HSCT after MG4101 treatment. Except for one grade 3 infusion-related reaction, no serious adverse events were observed. The sum of activating KIRs in responders tended to be higher than that in non-responders. Analyses of NKRL and KIR highlighted the importance of immunological mechanisms in treating myeloid neoplasms.

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2024.2414903DOI Listing

Publication Analysis

Top Keywords

patients
5
mg4101
4
mg4101 allogeneic
4
allogeneic natural
4
natural killer
4
killer cell
4
cell patients
4
patients relapsed
4
relapsed refractory
4
refractory acute
4

Similar Publications

Background: Cytomegalovirus (CMV) is a major cause of morbidity and mortality for transplant and immunocompromised patients. While cell-mediated immunity (CMI) is crucial for control of CMV and can influence the management of patients, commercial kits to measure CMI responses have only recently become available. In this study, we evaluated 2 different test kit platforms to determine their performance with the aim of implementing CMV-CMI testing to serve local needs.

View Article and Find Full Text PDF

Estimation of the minimal important change for Brief Pain Inventory in patients with persistent spinal pain.

Musculoskelet Sci Pract

September 2025

Department of Physiotherapy and Occupational Therapy, Aalborg University Hospital, Aalborg, 9000, Denmark; Aalborg University, Department of Clinical Medicine, Aalborg, 9000, Denmark.

Background: The Brief Pain Inventory (BPI) is a widely used tool for assessing pain severity and interference, aligning with the bio-psycho-social model. It has been validated in various languages for patients with persistent spinal pain. However, the Minimal Important Change (MIC), which represents the smallest change perceived as meaningful by patients, has not yet been explored for this patient population.

View Article and Find Full Text PDF

Artificial intelligence is revolutionizing health care, particularly in precision medicine and noninvasive diagnostics. Anemia, which is a widespread condition that affects billions of people worldwide, compromises oxygen transport due to low hemoglobin levels, which leads to severe complications if left undetected. Early and frequent monitoring is essential, yet traditional blood tests can be invasive, costly, and impractical for continuous assessment.

View Article and Find Full Text PDF

Introduction: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly prescribed for Type 2 diabetes and obesity due to their cardiometabolic benefits. However, their effects on fracture healing remain controversial. This study investigates perioperative GLP-1 RA use and outcomes following surgical treatment of lower extremity (LE) fractures.

View Article and Find Full Text PDF

Effects of dermal-fibroblast-derived ECM and dextran sulfate supplementation on osteoblast differentiation - results of a preliminary in vitro study.

Injury

August 2025

Department of Trauma Surgery, University and University Hospital of Zurich, Raemistr. 100, 8091 Zurich, Switzerland; Center for Preclinical Development, University and University Hospital of Zurich, Raemistr. 100, 8091 Zurich, Switzerland. Electronic address:

Background: Critical size bone defects represent a clinical challenge, associated with considerable morbidity, and frequently trigger the requirement of secondary procedure. To fill osseous gaps, multiple steps are required, such as proliferation and differentiation on the cellular level and the building of extracellular matrix. In addition, the osteogenic potential of cell-derived extracellular matrices (CD-ECM) is known to enhance bone healing.

View Article and Find Full Text PDF